|  |



Abacavir-Based ART Regimens Linked to Higher MACE Risk in Patients With HIV

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.


View article...


Top stories of the last 30 days